(c) 2024 PillSync.com

AbuseDeterrent Morphine Sulfate 30 MG Naltrexone hydrochloride 1.2 MG Extended Release Oral Capsule Embeda

1 INDICATIONS AND USAGE EMBEDA is indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. EMBEDA is a combination opioid agonist/opioid antagonist product indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. ( 1 ) Limitations of Use Because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses, and because of the greater risks of overdose and death with extended-release opioid formulations, reserve EMBEDA for use in patients for whom alternative treatment options (e.g., non-opioid analgesics or immediate-release opioids) are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain.( 1 ) EMBEDA is not indicated as an as-needed (prn) analgesic. ( 1 ) Limitations of Use Because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses, and because of the greater risks of overdose and death with extended-release opioid formulations [see Warnings and Precautions (5.1) ] , reserve EMBEDA for use in patients for whom alternative treatment options (e.g., non-opioid analgesics or immediate-release opioids) are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. EMBEDA is not indicated as an as-needed (prn) analgesic.

Pfizer Laboratories Div Pfizer Inc


4 years ago CAPSULE BLUE Embeda 30 AbuseDeterrent Morphine Sulfate 30 MG  Naltrexone hydrochloride 1.2 MG Extended Release Oral Capsule Embeda

CAPSULE BLUE Embeda 30

16 HOW SUPPLIED/STORAGE AND HANDLING EMBEDA 20 mg/0.8 mg EMBEDA 30 mg/1.2 mg EMBEDA 50 mg/2 mg EMBEDA 60 mg/2.4 mg EMBEDA 80 mg/3.2 mg EMBEDA 100 mg/4 mg Morphine sulfate 20 mg 30 mg 50 mg 60 mg 80 mg 100 mg Sequestered naltrexone hydrochloride 0.8 mg 1.2 mg 2 mg 2.4 mg 3.2 mg 4 mg Extended-Release capsule Description For all strengths, the darker-toned cap has "EMBEDA" printed in grey ink and a single grey band around ¾ of the circumference. Two-toned, yellow opaque hard gelatin capsule. The lighter-toned body has "20" reverse-printed in a grey circle. Two-toned, blue-violet opaque hard gelatin capsule. The lighter-toned body has "30" reverse-printed in a grey circle. Two-toned, blue opaque hard gelatin capsule. The lighter-toned body has "50" reverse-printed in a grey circle. Two-toned, pink opaque hard gelatin capsule. The lighter-toned body has "60" reverse-printed in a grey circle. Two-toned, light peach opaque elongated hard gelatin capsule. The lighter-toned body has "80" reverse-printed in a grey circle. Two-toned, green opaque hard gelatin capsule. The lighter-toned body has "100" reverse-printed in a grey circle. Bottle Size 75 cc 75 cc 75 cc 75 cc 75 cc 75 cc Bottle Count 30 capsules 30 capsules 30 capsules 30 capsules 30 capsules 30 capsules NDC # 60793-430-20 60793-431-20 60793-433-20 60793-434-20 60793-435-20 60793-437-20 Store at 25°C (77°F); excursions permitted between 15° and 30°C (59° and 86°F) [see USP Controlled Room Temperature]. Dispense in a sealed, tamper-evident, childproof, light-resistant container. Store EMBEDA securely and dispose of properly [see Patient Counseling Information (17) ] .


More pills like CAPSULE Embeda 30












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site